Crossmark

A patient with a homozygous diacylglycerol kinase epsilon (DGKE) gene mutation with atypical haemolytic uraemic syndrome and low C3 responded well to eculizumab: a case report

Crossref DOI link: https://doi.org/10.1186/s12882-021-02352-8

Published Online: 2021-04-20

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alabdulqader, Muneera

Alfakeeh, Khalid
License Information

Text and Data Mining valid from 2021-04-20

Version of Record valid from 2021-04-20
More Information

Article History

Received: 28 October 2020

Accepted: 12 April 2021

First Online: 20 April 2021

Declarations

:

: Since this was a case report in which the patient was not identified, the requirement for ethical approval was waived.

: Written consent for publication was obtained from the parents of the patient.

: There were no financial or non-financial competing interests.

Document is current

Any future updates will be listed below